CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Accumulated Deficit	Total
Balances, beginning of period at Dec. 31, 2022	$ 474,847	$ (464,818)	$ 10,029
Balances, beginning of period (in shares) at Dec. 31, 2022	118,480,878
Shares issued, net of offering costs	$ 1,013		1,013
Shares issued, net of offering costs (in shares)	1,710,068
Shares issued (RSUs vested, net of shares withheld)	$ (142)		$ (142)
Shares issued (RSUs vested, net of shares withheld) (in shares)	412,548
Shares issued (shares issued in exchange for vested DSUs) (in shares)	485,000		485,000
Stock-based compensation	$ 636		$ 636
Net income (loss)		(6,585)	(6,585)
Balances, end of period at Dec. 31, 2023	$ 476,354	(471,403)	4,951
Balances, end of period (in shares) at Dec. 31, 2023	121,088,494
Shares issued, net of offering costs	$ 1,108		1,108
Shares issued, net of offering costs (in shares)	1,722,966
Shares issued (RSUs vested, net of shares withheld)	$ (85)		$ (85)
Shares issued (RSUs vested, net of shares withheld) (in shares)	445,551
Shares issued (shares issued in exchange for vested DSUs) (in shares)	295,000		295,000
Stock-based compensation	$ 684		$ 684
Net income (loss)		11,249	11,249
Balances, end of period at Dec. 31, 2024	$ 478,061	$ (460,154)	$ 17,907
Balances, end of period (in shares) at Dec. 31, 2024	123,552,011